J&J Unit Denied Appeal Against Stelara Invalidation
A London judge has refused to permit Janssen Biotech Inc. to challenge his July decision nixing the patent on its blockbuster Stelara drug, saying he had used "no magic" when using...To view the full article, register now.
Already a subscriber? Click here to view full article